Lanutan, Sheila Jane B.
HRN: 13-25-75 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/08/2023
CEFTRIAXONE 1G (VIAL)
01/08/2023
01/14/2023
IV
2g
OD
UTI
Waiting Final Action